Mass spectrometric characterization of a discontinuous epitope of the HIV envelope protein HIV-gp120 recognized by the human monoclonal antibody 1331A

Journal of Immunology

Volumn 164, Issue 8, 2000, Pages 4156-4161

  Hochleitner, Elisabeth O ^a   Gorny, Miroslaw K ^b   Zolla Pazner, Susan ^b,c   Tomer, Kenneth B ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; HUMAN MONOCLONAL ANTIBODY;

ANALYTIC METHOD; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION;

EID: 0034655261     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.8.4156     Document Type: Article

References (38)

1. Klatzman, D. E., E. Champangne, S. Chamaret, J. Gruest, D. Guetard, T. Hercend, J.C. Gluckman, and L. Montagnier. 1984. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312:767.
2. + T cells by a complex of the 110K viral protein and the T4 molecule. Science 231:382.
3. Leonard, C. K., M. W. Spellman, L. Riddle, R. J. Harris, J. N. Thomas, and T. J. Gregory. 1990. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant immunodeficiency virus envelope glycoprotein (gp120) glycosylation sites expressed in Chinese Hamster Ovary cells. J. Biol. Chem. 265:10173.
4. Starcich, B. R., B. H. Hahn, G. M. Shaw, P. D. McNeely, S. Modrow, H. Wolf, E. S. Parks, W. P. Parks, S. F. Josephs, R. C. Gallo, and F. Wong-Staal. 1986. Identification and characterization of conserved and variable regions for the envelope gene HTLV-III/LAV, the retrovirus of AIDS. Cell 45:637.
5. Kwong, P. D., R. Wyatt, J. Robinson, R. W. Sweet, J. Sodroski, and W. A. Henrickson. 1998. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393: 648.
6. Profy, A. T., P. A. Salinas, L. I. Eckler, N. M. Dunlop, P. L. Nara, and S. D. Putney. 1990. Epitopes recognized by the neutralizing antibodies of an HlV-1 infected individual. J. Immunol. 144:4641.
7. Palker, T. J., M. E. Clark, A. J. Langlois, T. J. Matthews, K. J. Weinhold, R. R. Randall, D. P. Bolognesi, and B. F. Haynes. 1988. Type-specific neutralisation of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proc. Natl. Acad. Sci. USA 85:1932.
8. Goudsmit, J., C. Debouck, R. H. Meloen, L. Smit, M. Bakker, D. M. Asher, A. V. Wolff, C. J. Gibbs, and D. C. Gajdusek. 1988. Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc. Natl. Acad. Sci. USA 85:4478.
9. Conley, A. J., M. K. Gorny, J. A. Kessler, L. J. Boots, M. Ossorio-Castro, S. Koenig, D. W. Lineberger, E. A. Emini, C. Williams, and S. Zolla-Pazner. 1994. Neutralization of primary human immunodeficiency virus type I isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D. J. Virol. 68: 6994.
10. D'Souza, M. P., D. Livnat, J. A. Bradac, and S. H. Bridges. 1997. The AIDS clinical trials group antibody selection working group evaluation of monoclonal antibodies to human immunodeficiency virus type 1 isolates by neutralization assays: performance criteria for selecting candidate antibodies for clinical trials. J. Inject. Dis. 175:1056.
11. Gauduin, M. C., P. W. Parren, R. Weir, C. F. Barbas, D. R. Burton, and R. A. Koup. 1997. Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1. Nat. Med. 3:1389.
12. Andrus, L., A. M. Prince, I. Bernal, P. McCormack, D. H. Lee, M. K. Gorny, and S. Zolla-Pazner. 1998 Passive Immunization with a human immunodeficiency virus type 1-neutralizing monoclonal antibody in hu-PBL-SCID mice: isolation of a neutralization escape variant. J. Inject. Dis. 177:889.
13. Ferrer, M., B. J. Sullivan, K. L. Godbout, E. Burke, H. S. Stump, J. Godoy, A. Golden, A. T. Profy, and M. R. van Schravendijk. 1999. Structural and funclional characterization of an epitope in the conserved C-terminal region of HIV-1 gp120. J. Peptide Res. 54:32.
14. Keller, P. M., B. A. Arnold, A. R. Shaw, R. L. Tolman, F. V. Middlesworth, S. Bondy, V. K. Rusieki, S. Koenig, S. Zolla-Pazner, P. Conard, et al. 1992. Identification of HIV vaccine candidate peptides by screening random phage epitope libraries. Virology 193:709.
15. Boots, L .J., P. M. McKenna, B. A. Arnold, P. M. Keller, M. K. Gorny, S. Zolla-Pazner, J. E. Robinson, and A. J. Conley. 1997. Anti-human immunodeficiency virus type 1 human monoclonal antibodies that bind discontinuous epitopes in the viral glycoproteins can identify mimotopes from recombinant phage display libraries. AIDS Res. Hum. Retroviruses 13:1549.
16. Davies, D. R., and G. H. Cohen. 1996. Review: interactions of protein antigens with antibodies. Proc. Natl. Acad. Sci. USA 93:7.
17. Jemmersen, R., and Y. Paterson. 1986. Mapping epitopes on a protein antigen by the proteolysis of antigen-antibody complexes. Science 232:1001.
18. Burnens, A., G. Demotz, G. Corradin, H. Binz, and H. R. Bosshard. 1987. Epitope mapping by chemical modification of free and antibody bound protein antigen. Science 235:780.
19. Parker, C. E., D. I. Papac, S. K. Trojak, and K. B. Tomer. 1996. Epitope mapping by mass spectrometry. J. Immunol. 157:198.
20. Jeyarajah, S., C. E. Parker, M. T. Sumner, and K. B. Tomer. 1998. Matrix assisted laser desorption ionization/mass spectrometry mapping of human immunodeficiency virus-gp120 epilopes recognized by a limited polyclonal antibody. J. Am. Soc. Mass Spectrom. 9:157.
21. Gorny, M. K., V. Gianakakos, S. Sharpe, and S. Zolla-Pazner. 1989. Generation of human monoclonal antibodies to human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 86:1624.
22. Bandres, J. C., Q. F. Wang, J. O'Leary, F. Baleaux, A. Amara, J. A. Hoxie, S. Zolla-Pazner, and M. K. Gorny. 1998. Human immunodeficiency virus (HIV) envelope binds to CXCR4 independently of CD4. and binding can be enhaced by interaction with soluble CD4 or by HIV envelope deglycosylation. J. Virol. 72: 2500.
23. Nyambi, P. N., M. K. Gorny, L. Bastiani, G. van der Groen, C. Williams, and S. Zolla-Pazner. 1998. Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1. J. Virol. 72:9384.
24. Sanchez-Pescador, R., M. D. Power, P. J. Barr, K. S. Steimer, M. M. Stempien, S. L. Brown-Shimer, W. W. Gee, A. Renard, A. Randolph, J. A. Levy, D. Dina, and P. A. Luciw. 1984. Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). Science 227:484.
25. Jones, D. H., B. W. McBride, M. A. Roff, and G. H. Farrar. 1994. Efficient purification and rigorous characterization of a recombinant gp120 for HIV vaccine studies. Vaccine 13:991.
26. Palker, T. J., T. J. Matthews, M. E. Clark, G. J. Ciaciolo, R. R. Randall, A. J. Langlois, G. C. White, B. Safai, R. Snyderman, D. P. Bolognesi, et al. 1987. A conserved region of the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope. Proc. Natl. Acad. Sci. USA 84:2479.
27. Forthal, D. N., G. Landucci, M. K. Gorny, S. Zolla-Pazner, and W. E. Robinson, Jr. 1995. Functional activities of 20 human immunodeficiency virus type 1 (HIV-1)-specific human monoclonal antibodies. AIDS Res. Hum. Retroviruses. 11:1095.
28. Gorny, M. K., A. J. Conley, S. Karwowska, A. Buchbinder, J. Y. Xu, E. A. Emini, S. Koenig, and S. Zolla-Pazner. 1992. Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody. J. Virol. 66:7538.
29. Zolla-Pazner, S., J. O'Leary, S. Burda, M. K. Gorny, M. Kim, J. Mascola, and F. McCutchan. 1995. Serotyping of primary human immunodeficiency virus type 1 isolates from diverse geographic locations by flow cytometry. J. Virol. 69:3807.
30. Laal, S., S. Burda, M. K. Gorny, S. Karwowska, A. Buchbinder, and S. Zolla-Pazner. 1994. Synergistic neutralization of human immunodeficiency virus type 1 by combinations of human monoclonal antibodies. J. Virol. 68:4001.
31. Hansen, J. E., O. Lund, J. O. Nielsen, S. Brunak, and J. E. S. Hansen. 1996. Prediction of the secondary structure of HIV-1 gp120. Proteins 25:1.
32. Schultz, T. L., B. A. Jameson, L. Lopalco, A. G. Siccardi, R. A. Weiss, and J. P. Moore. 1992. Conserved structural features in the interaction between retroviral surface and transmembrane glycoproteins? AIDS Res. Hum. Retroviruses 8:1571.
33. Helseth, E., U. Olshevski, C. Furman, and J. Sodrowski. 1991. Human immunodeficiency virus type 1 gp120 envelope glycoprotein regions important for association with the gp41 transmembrane glycoprotein. J. Virol. 65:2119.
34. Lopalco, L., C. De Santis, R. Meneveri, R. Longhi, E. Ginelli, F. Grassi, A. G. Siccardi, and A. Beretta. 1993. Human immunodeficiency virus type 1 gp120 C5 region mimics the HLA class I α1 peptide-binding domain. Eur. J. Immunol. 23:2016.
35. el-Zaatari, F. A., K. C. Sams, and J. D. Taurog. 1990. In vitro mutagenesis of HLA-B27. Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain. J. Immunol. 144:1512.
36. Gomme, P. T., P. G. Stanton, and M. T. Hearn. 1999. Evaluation of a pepscan approach to identify epitopes recognized by anti-hTSH monoclonal antibodies. J. Biochem. Biophys. Methods 38:53.
37. Fiedler, W., C. Borchers, M. Macht, S, Deininger, and M. Przybylski. 1998. Molecular characterization of a conformational epitope of hen egg white lysozyme by differential chemical modification of immune complexes and mass spectrometric peptide mapping. Bioconj. Chem. 9:236.
38. Zhao, Y., and B. T. Chait. 1994. Protein epitope mapping by mass spectrometry. Anal. Chem. 66:3723.